Achilles Therapeutics (ACHL) Projected to Announce Quarterly Earnings on Thursday

Achilles Therapeutics (NASDAQ:ACHL) is expected to post its quarterly earnings results before the market opens on Thursday, April 3rd. Analysts expect Achilles Therapeutics to post earnings of ($0.36) per share for the quarter.

Achilles Therapeutics Stock Performance

Shares of ACHL opened at $1.48 on Thursday. Achilles Therapeutics has a one year low of $0.63 and a one year high of $1.51. The stock has a 50-day moving average price of $1.34 and a 200 day moving average price of $1.13. The company has a market capitalization of $60.83 million, a P/E ratio of -0.90 and a beta of 1.25.

About Achilles Therapeutics

Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient.